In experiments on laboratory animals, a monotherapy of solid cancer against directed to CD133+ CTCs showed inhibition of tumor growth in an orthotopic mouse model of glioma (Zhu et al., 2015; Hu et al., 2019). Here, PROM1 is linked to neoplasm.